E2F5 and neoplasm: As a transcription factor, E2F5 may participate in shaping the LSCC tumor microenvironment by directly or indirectly regulating the expression of NETs hallmark genes (e.g., S100A8/A9, LCN2), thereby influencing tumor progression.